Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions.
Megyesfalvi Z, Gay CM, Popper H, Pirker R, Ostoros G, Heeke S, Lang C, Hoetzenecker K, Schwendenwein A, Boettiger K, Bunn PA Jr, Renyi-Vamos F, Schelch K, Prosch H, Byers LA, Hirsch FR, Dome B. Megyesfalvi Z, et al. Among authors: schwendenwein a. CA Cancer J Clin. 2023 Nov-Dec;73(6):620-652. doi: 10.3322/caac.21785. Epub 2023 Jun 17. CA Cancer J Clin. 2023. PMID: 37329269 Free article. Review.
Comparative expression analysis of immune-related markers in surgically resected lung neuroendocrine neoplasms.
Ferencz B, Megyesfalvi Z, Csende K, Fillinger J, Poór V, Lantos A, Pipek O, Sólyom-Tisza A, Rényi-Vámos F, Schelch K, Lang C, Schwendenwein A, Boettiger K, László V, Hoetzenecker K, Döme B, Berta J. Ferencz B, et al. Among authors: schwendenwein a. Lung Cancer. 2023 Jul;181:107263. doi: 10.1016/j.lungcan.2023.107263. Epub 2023 May 30. Lung Cancer. 2023. PMID: 37270937 Free article.
Dual targeting of BCL-2 and MCL-1 in the presence of BAX breaks venetoclax resistance in human small cell lung cancer.
Valko Z, Megyesfalvi Z, Schwendenwein A, Lang C, Paku S, Barany N, Ferencz B, Horvath-Rozsas A, Kovacs I, Schlegl E, Pozonec V, Boettiger K, Rezeli M, Marko-Varga G, Renyi-Vamos F, Hoda MA, Klikovits T, Hoetzenecker K, Grusch M, Laszlo V, Dome B, Schelch K. Valko Z, et al. Among authors: schwendenwein a. Br J Cancer. 2023 May;128(10):1850-1861. doi: 10.1038/s41416-023-02219-9. Epub 2023 Mar 14. Br J Cancer. 2023. PMID: 36918717 Free PMC article.
Proteomic analysis of brain metastatic lung adenocarcinoma reveals intertumoral heterogeneity and specific alterations associated with the timing of brain metastases.
Woldmar N, Schwendenwein A, Kuras M, Szeitz B, Boettiger K, Tisza A, László V, Reiniger L, Bagó AG, Szállási Z, Moldvay J, Szász AM, Malm J, Horvatovich P, Pizzatti L, Domont GB, Rényi-Vámos F, Hoetzenecker K, Hoda MA, Marko-Varga G, Schelch K, Megyesfalvi Z, Rezeli M, Döme B. Woldmar N, et al. Among authors: schwendenwein a. ESMO Open. 2023 Feb;8(1):100741. doi: 10.1016/j.esmoop.2022.100741. Epub 2022 Dec 16. ESMO Open. 2023. PMID: 36527824 Free PMC article.
Clinical and prognostic implications of CD47 and PD-L1 expression in surgically resected small-cell lung cancer.
Lang C, Lantos A, Megyesfalvi Z, Egger F, Hoda MA, Mosleh B, Klikovits T, Oberndorfer F, Timelthaler G, Ferencz B, Fillinger J, Schwendenwein A, Querner AS, Boettiger K, Renyi-Vamos F, Hoetzenecker K, Laszlo V, Schelch K, Dome B. Lang C, et al. Among authors: schwendenwein a. ESMO Open. 2022 Dec;7(6):100631. doi: 10.1016/j.esmoop.2022.100631. Epub 2022 Nov 16. ESMO Open. 2022. PMID: 36399951 Free PMC article.
In-depth proteomic analysis reveals unique subtype-specific signatures in human small-cell lung cancer.
Szeitz B, Megyesfalvi Z, Woldmar N, Valkó Z, Schwendenwein A, Bárány N, Paku S, László V, Kiss H, Bugyik E, Lang C, Szász AM, Pizzatti L, Bogos K, Hoda MA, Hoetzenecker K, Marko-Varga G, Horvatovich P, Döme B, Schelch K, Rezeli M. Szeitz B, et al. Among authors: schwendenwein a. Clin Transl Med. 2022 Sep;12(9):e1060. doi: 10.1002/ctm2.1060. Clin Transl Med. 2022. PMID: 36149789 Free PMC article.
Lymphocyte-to-monocyte ratio is an independent prognostic factor in surgically treated small cell lung cancer: An international multicenter analysis.
Lang C, Egger F, Alireza Hoda M, Saeed Querner A, Ferencz B, Lungu V, Szegedi R, Bogyo L, Torok K, Oberndorfer F, Klikovits T, Schwendenwein A, Boettiger K, Renyi-Vamos F, Hoetzenecker K, Schelch K, Megyesfalvi Z, Dome B. Lang C, et al. Among authors: schwendenwein a. Lung Cancer. 2022 Jul;169:40-46. doi: 10.1016/j.lungcan.2022.05.010. Epub 2022 May 18. Lung Cancer. 2022. PMID: 35643059 Free article.
Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small-cell lung cancer: an international multicenter study.
Megyesfalvi Z, Barany N, Lantos A, Valko Z, Pipek O, Lang C, Schwendenwein A, Oberndorfer F, Paku S, Ferencz B, Dezso K, Fillinger J, Lohinai Z, Moldvay J, Galffy G, Szeitz B, Rezeli M, Rivard C, Hirsch FR, Brcic L, Popper H, Kern I, Kovacevic M, Skarda J, Mittak M, Marko-Varga G, Bogos K, Renyi-Vamos F, Hoda MA, Klikovits T, Hoetzenecker K, Schelch K, Laszlo V, Dome B. Megyesfalvi Z, et al. Among authors: schwendenwein a. J Pathol. 2022 Aug;257(5):674-686. doi: 10.1002/path.5922. Epub 2022 May 25. J Pathol. 2022. PMID: 35489038 Free PMC article.
Clinical relevance of circulating activin A and follistatin in small cell lung cancer.
Barany N, Rozsas A, Megyesfalvi Z, Grusch M, Hegedus B, Lang C, Boettiger K, Schwendenwein A, Tisza A, Renyi-Vamos F, Schelch K, Hoetzenecker K, Hoda MA, Paku S, Laszlo V, Dome B. Barany N, et al. Among authors: schwendenwein a. Lung Cancer. 2021 Nov;161:128-135. doi: 10.1016/j.lungcan.2021.09.008. Epub 2021 Sep 20. Lung Cancer. 2021. PMID: 34583221 Free article.
Molecular profiles of small cell lung cancer subtypes: therapeutic implications.
Schwendenwein A, Megyesfalvi Z, Barany N, Valko Z, Bugyik E, Lang C, Ferencz B, Paku S, Lantos A, Fillinger J, Rezeli M, Marko-Varga G, Bogos K, Galffy G, Renyi-Vamos F, Hoda MA, Klepetko W, Hoetzenecker K, Laszlo V, Dome B. Schwendenwein A, et al. Mol Ther Oncolytics. 2021 Feb 6;20:470-483. doi: 10.1016/j.omto.2021.02.004. eCollection 2021 Mar 26. Mol Ther Oncolytics. 2021. PMID: 33718595 Free PMC article. Review.
11 results